Celluminova specializes in developing new tools for stem cell research, including cancer stem cells. The patented biomarker GlioStem® is intended for live stem cell detection and visualization.
We specialize in developing new tools for stem cells research, including cancer stem cells.
The patented biomarker GlioStem® is intended for the detection and visualization of stem cell-like cells in brain tumors. Today, there are no products on the market that target stem-like cells in these tumors. The goal for GlioStem® is to be used during surgery to completely remove tumor tissue and thereby potentially lead to increased patient survival.
GlioStem® is a new product designed for near-instant detection of glioma stem cells.
It is based on polymer technology and defines a new generation of biomarkers.
